United States Antimony Corporation

Based on a comprehensive analysis of UAMY, the stock presents a highly speculative and risky profile that is difficult to recommend for most investors.

From a technical perspective, the stock is in a volatile transition phase after a sharp rally, having recently pulled back. Fundamentally, the picture is concerning; the company is experiencing declining revenue, a significant quarterly loss, negative cash flow, and poor operational efficiency, overshadowing its solid liquidity position. While the low beta suggests its price moves independently of the market, this highlights extreme idiosyncratic risk and illiquidity, making it prone to severe drawdowns. Traditional valuation is impossible due to negative earnings, leaving no clear benchmark for its price.

Recommendation: Not a Buy. UAMY is a highly speculative play suitable only for investors who can tolerate extreme volatility and potential total loss. The severe operational deterioration and lack of profitability create substantial fundamental risk that outweighs any perceived technical opportunity. Investors should seek more stable opportunities with clearer financial health.

RockFlow Model Forecast: Three Scenarios for 2026

Based on a comprehensive analysis, the 12-month outlook for UAMY is highly unfavorable.

Key catalysts for any positive price movement are virtually nonexistent and would likely require a dramatic, unforeseen turnaround, such as a surge in antimony prices or a major new contract that immediately reverses the company's declining revenue and negative cash flow.

Potential risks are severe and dominate the outlook, primarily centered on continued operational deterioration, deepening quarterly losses, and the potential for significant illiquidity and price volatility that could lead to substantial capital erosion.

Given the absence of analyst targets and the company's negative financial metrics, establishing a justified target price range is not feasible. The stock is best viewed as a highly speculative instrument with a significant risk of loss, rather than a traditional investment. Investors should anticipate high volatility with a downward bias unless fundamental performance improves dramatically.

Wall Street Consensus

Most Wall Street analysts are optimistic about United States Antimony Corporation's 12-month outlook, with consensus target around $8.94, indicating expected upside potential.

Overall, UAMY has investment potential but also faces challenges. Here are key factors to weigh before investing.

UAMY has demonstrated extreme volatility over the past year, showcasing both significant gains and substantial losses, reflecting its highly speculative nature.

The stock has struggled recently with a nearly 8% decline over the past month, but this is contrasted by a strong 52% surge over three months, during which it meaningfully outperformed the broader market by over 48%. This indicates a sharp, recent reversal following a powerful rally. Currently trading at $8.94, the price sits in the lower-middle portion of its extremely wide 52-week range ($1.21-$19.71), approximately 40% above its low. Given the recent monthly decline from higher levels, the stock appears to be moving away from overbought conditions but remains well above its deep lows, suggesting a potential state of transition.

Revenue & Profitability: UAMY's revenue declined from $10.5 million in Q2 to $8.7 million in Q3, while profitability deteriorated sharply from a small net income to a significant $4.8 million loss. This was driven by a steep drop in gross margin to 23.1% and a substantial increase in SG&A expenses, resulting in a deeply negative operating margin of -56.5% for the quarter.

Financial Health: The company maintains a strong liquidity position with current and quick ratios above 3.7, supported by a substantial cash ratio of 2.93. However, it generated negative operating cash flow, and the cash flow to debt ratio is deeply negative, indicating a weak ability to service obligations from core operations despite minimal debt on the balance sheet.

Operational Efficiency: Operational metrics reflect significant challenges, with a negative return on equity of -6.7% and a negative return on assets of -6.0%. Asset turnover is low at 0.11, and inventory turnover is particularly weak at 0.80, suggesting inefficient use of assets and potential inventory management issues impacting overall performance.

Valuation Level A meaningful PE ratio analysis is not possible for UAMY, as both its trailing-twelve-month and forward PE ratios are negative (-223 and -40.0, respectively), indicating that the company is currently unprofitable. Similarly, the negative EV/EBITDA ratio of -166.0 confirms a lack of earnings and cash flow, making traditional valuation metrics irrelevant. Since profitability is absent, the valuation cannot be quantitatively assessed as overvalued or undervalued based on earnings multiples alone.

Peer Comparison Unfortunately, a peer comparison is not feasible as industry average data is unavailable. Without industry benchmarks for PB, PEG, or EV/EBITDA ratios, it's impossible to contextualize UAMY's elevated price-to-book ratio of 17.39 or its reported PEG ratio of 0.014. As such, no relative valuation assessment can be made until appropriate industry comparables are provided.

Volatility Risk

UAMY's extremely low beta of 0.018 suggests its price movements are almost entirely detached from the broader market swings, indicating specific, non-systemic volatility. This is corroborated by a severe one-year maximum drawdown of -74.3%, which points to extreme idiosyncratic risk and high potential for significant capital depreciation, regardless of general market conditions.

Other Risks

The lack of reported short interest is not necessarily positive, as it often reflects extremely low stock liquidity and negligible trading interest from institutional investors. This illiquidity itself is a primary risk, potentially leading to wide bid-ask spreads and difficulty exiting positions without substantial price impact.